Health Minister Mike Nesbitt has published Northern Ireland’s new Cancer Research Strategic Framework designed to strengthen cancer research, innovation and collaboration across Northern Ireland.

The Framework sets out a clear direction for enhancing research excellence, removing barriers, increasing participation in clinical trials, and improving outcomes for cancer patients. It builds on the ambitions of the NI Cancer Strategy and aligns with the Health and Care Reset Plan commitment to develop a world-leading health and care research and innovation ecosystem.

A new Cancer Research Advisory Group will oversee delivery of the Framework. The Group will be co-chaired by Professor Ian Young, Chief Scientific Adviser at the Department of Health, and Professor Mark Lawler, Professor of Digital Health and Chair in Translational Cancer Genomics at Queen’s University Belfast, with Cancer Research UK as a key member.

Health Minister Mike Nesbitt said,

“This Framework demonstrates a clear commitment to strengthening cancer research in Northern Ireland. By uniting expertise across health and social care, academia, industry and the voluntary sector, we can accelerate progress and deliver real improvements in prevention, diagnosis and treatment.

“Our researchers and clinicians already make an outstanding contribution to cancer care. This Framework ensures they are supported to continue that work, driving innovation that will translate directly into better outcomes for patients. I am very grateful to everyone who has contributed to its development.”